| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pharmacology and Experimental Therapeutics [S. L. P., C. F., M. A.], Department of Obstetrics and Gynecology [N. B. R.], and the Oncology Center [R. G. M., R. B. B., M. C.], The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
An unambiguous and sensitive method based on gas chromatography-chemical ionization-mass spectrometry has been developed to quantitate L-phenylalanine mustard and has been applied to measure levels in plasma of five patients receiving 0.15 to 0.25 mg/kg (10 to 17 mg) of the drug p.o. Peak plasma levels of 50 to 190 ng/ml were found to occur between 0.7 and 2.3 hr after ingestion. The time for the plasma level to fall to one-half of the peak value varied from 0.6 to 3 hr, and very low levels (<2 ng/ml) were present by 24 hr.
1 This research was supported by USPHS NIH Grants CA-16783, CA-00103, GM-21248, and CA-00673. These data were presented in part at the 27th Annual Conference on Mass Spectrometry and Allied Topics, Seattle, Wash., June 3 to 8, 1979.
2 To whom requests for reprints should be addressed, at the Department of Pharmacology and Experimental Therapeutics, 725 North Wolfe Street, Baltimore, Md., 21205.
Received 10/15/79. Accepted 3/21/80.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |